Diagnosis, Risk Stratification, And Management Of Pulmonary Hypertension Of Sickle Cell Disease.
Key Points
Key Points
Observational studies have consistently shown that increased tricuspid regurgitant jet velocity (TRV) measured by Doppler echocardiography, an increased serum N-terminal pro–brain natriuretic peptide (NT-pro-BNP) level, and pulmonary hypertension measured by right heart catheterization are all independent risk factors for mortality in adults.
To reduce the variability and to improve the quality of care that patients with SCD receive, the ATS developed clinical practice guidelines to advise hematologists, pulmonologists, cardiologists, pediatricians, and internists about how to identify and manage patients with SCD who are at increased risk for mortality.
Diagnosis
Diagno...
...sk stratification guides clinical decision mak...
...ased risk for mortality is defined as a TR...
...Sample Questions for Evaluation of Dys...
...1. Proposed Algorithm for Evaluation of Pulmonar...
...2. Echocardiogram of a Patient with Pulmonar...
Treatment
Treatm...
...tients with SCD who have an increased risk fo...
...th SCD who have an increased risk for mortality an...
...atients with SCD who have RHC-confirmed...
...atients with SCD who have elevated TRV a...
...patients with SCD who have RHC-confirmed P...
...elect patients with SCD who have RHC-confirmed mar...
...patients with SCD who have RHC-confirmed mar...
...ationsHaving trouble viewing table? Ex...